orthumbria Osteoporosis Project: A randomised controlled trial of managing patients needing bone protection treatment through group clinics vs usual one to one care

orth Tyneside General Hospital0 sites214 target enrollmentSeptember 1, 2017

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Specialty: Musculoskeletal disorders, Primary sub-specialty: Metabolic Bone Disease
Sponsor: orth Tyneside General Hospital
Enrollment: 214
Status: Completed
Last Updated: 8 years ago

No summary available.

Registry

who.int

Start Date

September 1, 2017

End Date

TBD

Last Updated

8 years ago

Study Type

Interventional

Sex

All

Sponsor

orth Tyneside General Hospital

•1\. Patients identified as high risk of an osteoporotic fracture, needing treatment
•2\. Patients aged 50 years and over
•3\. Patients giving informed consent to the study

•1\. Patients not eligible for first line treatment as defined by North of Tyne Osteoporosis Guidance (encompassing FRAX calculation and NOGG guideline)
•2\. Patients not wishing to participate in the study
•3\. Patients unable to consent to participate in the study
•4\. Patient contraindications to bisphosphonates (upper gastrointestinal problems, severe impairment GFR\<35ml/min, previous intolerance)
•5\. Terminally ill patients
•6\. Housebound patients